SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036214
Filing Date
2023-11-02
Accepted
2023-11-02 07:51:40
Documents
88
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20230930.htm   iXBRL 10-Q 1383159
2 EX-31.1 lnth10q-093023ex311.htm EX-31.1 11667
3 EX-31.2 lnth10q-093023ex312.htm EX-31.2 11567
4 EX-32.1 lnth10q-093023ex321.htm EX-32.1 9750
  Complete submission text file 0001628280-23-036214.txt   7616607

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20230930.xsd EX-101.SCH 53370
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20230930_cal.xml EX-101.CAL 89017
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20230930_def.xml EX-101.DEF 204554
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20230930_lab.xml EX-101.LAB 721625
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20230930_pre.xml EX-101.PRE 447230
82 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20230930_htm.xml XML 1150210
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 231370135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances